The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Icosapent Ethyl Soft Capsules Market Research Report 2025
Synopsis
The global Icosapent Ethyl Soft Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Icosapent Ethyl Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Icosapent Ethyl Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Icosapent Ethyl Soft Capsules include Amarin, Sichuan Gowell Pharmaceutical, Amneal and Humanwell Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Icosapent Ethyl Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Icosapent Ethyl Soft Capsules.
Report Scope
The Icosapent Ethyl Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Icosapent Ethyl Soft Capsules market comprehensively. Regional market sizes, concerning products by Specification, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Icosapent Ethyl Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Specification, by Application, and by regions.
Market Segmentation
By Company
Amarin
Sichuan Gowell Pharmaceutical
Amneal
Humanwell Healthcare
Segment by Specification
0.5g
1.0g
Segment by Application
Hospital Pharmaty
Retail Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Specification, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Icosapent Ethyl Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Icosapent Ethyl Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Icosapent Ethyl Soft Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Icosapent Ethyl Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Icosapent Ethyl Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Icosapent Ethyl Soft Capsules include Amarin, Sichuan Gowell Pharmaceutical, Amneal and Humanwell Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Icosapent Ethyl Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Icosapent Ethyl Soft Capsules.
Report Scope
The Icosapent Ethyl Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Icosapent Ethyl Soft Capsules market comprehensively. Regional market sizes, concerning products by Specification, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Icosapent Ethyl Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Specification, by Application, and by regions.
Market Segmentation
By Company
Amarin
Sichuan Gowell Pharmaceutical
Amneal
Humanwell Healthcare
Segment by Specification
0.5g
1.0g
Segment by Application
Hospital Pharmaty
Retail Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Specification, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Icosapent Ethyl Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Icosapent Ethyl Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Icosapent Ethyl Soft Capsules Market Overview
1.1 Product Overview and Scope of Icosapent Ethyl Soft Capsules
1.2 Icosapent Ethyl Soft Capsules Segment by Specification
1.2.1 Global Icosapent Ethyl Soft Capsules Market Value Comparison by Specification (2024-2030)
1.2.2 0.5g
1.2.3 1.0g
1.3 Icosapent Ethyl Soft Capsules Segment by Application
1.3.1 Global Icosapent Ethyl Soft Capsules Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmaty
1.3.3 Retail Pharmacy
1.4 Global Icosapent Ethyl Soft Capsules Market Size Estimates and Forecasts
1.4.1 Global Icosapent Ethyl Soft Capsules Revenue 2019-2030
1.4.2 Global Icosapent Ethyl Soft Capsules Sales 2019-2030
1.4.3 Global Icosapent Ethyl Soft Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Icosapent Ethyl Soft Capsules Market Competition by Manufacturers
2.1 Global Icosapent Ethyl Soft Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Icosapent Ethyl Soft Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Icosapent Ethyl Soft Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Icosapent Ethyl Soft Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Icosapent Ethyl Soft Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Icosapent Ethyl Soft Capsules, Product Type & Application
2.7 Icosapent Ethyl Soft Capsules Market Competitive Situation and Trends
2.7.1 Icosapent Ethyl Soft Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Icosapent Ethyl Soft Capsules Players Market Share by Revenue
2.7.3 Global Icosapent Ethyl Soft Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Icosapent Ethyl Soft Capsules Retrospective Market Scenario by Region
3.1 Global Icosapent Ethyl Soft Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Icosapent Ethyl Soft Capsules Global Icosapent Ethyl Soft Capsules Sales by Region: 2019-2030
3.2.1 Global Icosapent Ethyl Soft Capsules Sales by Region: 2019-2024
3.2.2 Global Icosapent Ethyl Soft Capsules Sales by Region: 2025-2030
3.3 Global Icosapent Ethyl Soft Capsules Global Icosapent Ethyl Soft Capsules Revenue by Region: 2019-2030
3.3.1 Global Icosapent Ethyl Soft Capsules Revenue by Region: 2019-2024
3.3.2 Global Icosapent Ethyl Soft Capsules Revenue by Region: 2025-2030
3.4 North America Icosapent Ethyl Soft Capsules Market Facts & Figures by Country
3.4.1 North America Icosapent Ethyl Soft Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Icosapent Ethyl Soft Capsules Sales by Country (2019-2030)
3.4.3 North America Icosapent Ethyl Soft Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icosapent Ethyl Soft Capsules Market Facts & Figures by Country
3.5.1 Europe Icosapent Ethyl Soft Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Icosapent Ethyl Soft Capsules Sales by Country (2019-2030)
3.5.3 Europe Icosapent Ethyl Soft Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Icosapent Ethyl Soft Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Icosapent Ethyl Soft Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Icosapent Ethyl Soft Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Icosapent Ethyl Soft Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Icosapent Ethyl Soft Capsules Market Facts & Figures by Country
3.7.1 Latin America Icosapent Ethyl Soft Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Icosapent Ethyl Soft Capsules Sales by Country (2019-2030)
3.7.3 Latin America Icosapent Ethyl Soft Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Icosapent Ethyl Soft Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Icosapent Ethyl Soft Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Icosapent Ethyl Soft Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Icosapent Ethyl Soft Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Specification
4.1 Global Icosapent Ethyl Soft Capsules Sales by Specification (2019-2030)
4.1.1 Global Icosapent Ethyl Soft Capsules Sales by Specification (2019-2024)
4.1.2 Global Icosapent Ethyl Soft Capsules Sales by Specification (2025-2030)
4.1.3 Global Icosapent Ethyl Soft Capsules Sales Market Share by Specification (2019-2030)
4.2 Global Icosapent Ethyl Soft Capsules Revenue by Specification (2019-2030)
4.2.1 Global Icosapent Ethyl Soft Capsules Revenue by Specification (2019-2024)
4.2.2 Global Icosapent Ethyl Soft Capsules Revenue by Specification (2025-2030)
4.2.3 Global Icosapent Ethyl Soft Capsules Revenue Market Share by Specification (2019-2030)
4.3 Global Icosapent Ethyl Soft Capsules Price by Specification (2019-2030)
5 Segment by Application
5.1 Global Icosapent Ethyl Soft Capsules Sales by Application (2019-2030)
5.1.1 Global Icosapent Ethyl Soft Capsules Sales by Application (2019-2024)
5.1.2 Global Icosapent Ethyl Soft Capsules Sales by Application (2025-2030)
5.1.3 Global Icosapent Ethyl Soft Capsules Sales Market Share by Application (2019-2030)
5.2 Global Icosapent Ethyl Soft Capsules Revenue by Application (2019-2030)
5.2.1 Global Icosapent Ethyl Soft Capsules Revenue by Application (2019-2024)
5.2.2 Global Icosapent Ethyl Soft Capsules Revenue by Application (2025-2030)
5.2.3 Global Icosapent Ethyl Soft Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Icosapent Ethyl Soft Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amarin
6.1.1 Amarin Corporation Information
6.1.2 Amarin Description and Business Overview
6.1.3 Amarin Icosapent Ethyl Soft Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amarin Icosapent Ethyl Soft Capsules Product Portfolio
6.1.5 Amarin Recent Developments/Updates
6.2 Sichuan Gowell Pharmaceutical
6.2.1 Sichuan Gowell Pharmaceutical Corporation Information
6.2.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.2.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Soft Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Soft Capsules Product Portfolio
6.2.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.3 Amneal
6.3.1 Amneal Corporation Information
6.3.2 Amneal Description and Business Overview
6.3.3 Amneal Icosapent Ethyl Soft Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amneal Icosapent Ethyl Soft Capsules Product Portfolio
6.3.5 Amneal Recent Developments/Updates
6.4 Humanwell Healthcare
6.4.1 Humanwell Healthcare Corporation Information
6.4.2 Humanwell Healthcare Description and Business Overview
6.4.3 Humanwell Healthcare Icosapent Ethyl Soft Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Humanwell Healthcare Icosapent Ethyl Soft Capsules Product Portfolio
6.4.5 Humanwell Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Icosapent Ethyl Soft Capsules Industry Chain Analysis
7.2 Icosapent Ethyl Soft Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icosapent Ethyl Soft Capsules Production Mode & Process
7.4 Icosapent Ethyl Soft Capsules Sales and Marketing
7.4.1 Icosapent Ethyl Soft Capsules Sales Channels
7.4.2 Icosapent Ethyl Soft Capsules Distributors
7.5 Icosapent Ethyl Soft Capsules Customers
8 Icosapent Ethyl Soft Capsules Market Dynamics
8.1 Icosapent Ethyl Soft Capsules Industry Trends
8.2 Icosapent Ethyl Soft Capsules Market Drivers
8.3 Icosapent Ethyl Soft Capsules Market Challenges
8.4 Icosapent Ethyl Soft Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Icosapent Ethyl Soft Capsules Market Value Comparison by Specification (2024-2030) & (US$ Million)
Table 2. Global Icosapent Ethyl Soft Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Icosapent Ethyl Soft Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Icosapent Ethyl Soft Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Icosapent Ethyl Soft Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Icosapent Ethyl Soft Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Icosapent Ethyl Soft Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Icosapent Ethyl Soft Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Icosapent Ethyl Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Icosapent Ethyl Soft Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Icosapent Ethyl Soft Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Icosapent Ethyl Soft Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Icosapent Ethyl Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icosapent Ethyl Soft Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Icosapent Ethyl Soft Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Icosapent Ethyl Soft Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Icosapent Ethyl Soft Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Icosapent Ethyl Soft Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Icosapent Ethyl Soft Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Icosapent Ethyl Soft Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Icosapent Ethyl Soft Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Icosapent Ethyl Soft Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Icosapent Ethyl Soft Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Icosapent Ethyl Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Icosapent Ethyl Soft Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Icosapent Ethyl Soft Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Icosapent Ethyl Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Icosapent Ethyl Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Icosapent Ethyl Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Icosapent Ethyl Soft Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Icosapent Ethyl Soft Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Icosapent Ethyl Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Icosapent Ethyl Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Icosapent Ethyl Soft Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Icosapent Ethyl Soft Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Icosapent Ethyl Soft Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Icosapent Ethyl Soft Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Icosapent Ethyl Soft Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Icosapent Ethyl Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Icosapent Ethyl Soft Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Icosapent Ethyl Soft Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Icosapent Ethyl Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Icosapent Ethyl Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Icosapent Ethyl Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Icosapent Ethyl Soft Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Icosapent Ethyl Soft Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Icosapent Ethyl Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Icosapent Ethyl Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Icosapent Ethyl Soft Capsules Sales (K Units) by Specification (2019-2024)
Table 51. Global Icosapent Ethyl Soft Capsules Sales (K Units) by Specification (2025-2030)
Table 52. Global Icosapent Ethyl Soft Capsules Sales Market Share by Specification (2019-2024)
Table 53. Global Icosapent Ethyl Soft Capsules Sales Market Share by Specification (2025-2030)
Table 54. Global Icosapent Ethyl Soft Capsules Revenue (US$ Million) by Specification (2019-2024)
Table 55. Global Icosapent Ethyl Soft Capsules Revenue (US$ Million) by Specification (2025-2030)
Table 56. Global Icosapent Ethyl Soft Capsules Revenue Market Share by Specification (2019-2024)
Table 57. Global Icosapent Ethyl Soft Capsules Revenue Market Share by Specification (2025-2030)
Table 58. Global Icosapent Ethyl Soft Capsules Price (US$/Unit) by Specification (2019-2024)
Table 59. Global Icosapent Ethyl Soft Capsules Price (US$/Unit) by Specification (2025-2030)
Table 60. Global Icosapent Ethyl Soft Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Icosapent Ethyl Soft Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Icosapent Ethyl Soft Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Icosapent Ethyl Soft Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Icosapent Ethyl Soft Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Icosapent Ethyl Soft Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Icosapent Ethyl Soft Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Icosapent Ethyl Soft Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Icosapent Ethyl Soft Capsules Price (US$/Unit) by Application (2019-2024)
Table 69. Global Icosapent Ethyl Soft Capsules Price (US$/Unit) by Application (2025-2030)
Table 70. Amarin Corporation Information
Table 71. Amarin Description and Business Overview
Table 72. Amarin Icosapent Ethyl Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Amarin Icosapent Ethyl Soft Capsules Product
Table 74. Amarin Recent Developments/Updates
Table 75. Sichuan Gowell Pharmaceutical Corporation Information
Table 76. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 77. Sichuan Gowell Pharmaceutical Icosapent Ethyl Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sichuan Gowell Pharmaceutical Icosapent Ethyl Soft Capsules Product
Table 79. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 80. Amneal Corporation Information
Table 81. Amneal Description and Business Overview
Table 82. Amneal Icosapent Ethyl Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Amneal Icosapent Ethyl Soft Capsules Product
Table 84. Amneal Recent Developments/Updates
Table 85. Humanwell Healthcare Corporation Information
Table 86. Humanwell Healthcare Description and Business Overview
Table 87. Humanwell Healthcare Icosapent Ethyl Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Humanwell Healthcare Icosapent Ethyl Soft Capsules Product
Table 89. Humanwell Healthcare Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Icosapent Ethyl Soft Capsules Distributors List
Table 93. Icosapent Ethyl Soft Capsules Customers List
Table 94. Icosapent Ethyl Soft Capsules Market Trends
Table 95. Icosapent Ethyl Soft Capsules Market Drivers
Table 96. Icosapent Ethyl Soft Capsules Market Challenges
Table 97. Icosapent Ethyl Soft Capsules Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Icosapent Ethyl Soft Capsules
Figure 2. Global Icosapent Ethyl Soft Capsules Market Value Comparison by Specification (2024-2030) & (US$ Million)
Figure 3. Global Icosapent Ethyl Soft Capsules Market Share by Specification in 2023 & 2030
Figure 4. 0.5g Product Picture
Figure 5. 1.0g Product Picture
Figure 6. Global Icosapent Ethyl Soft Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Icosapent Ethyl Soft Capsules Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmaty
Figure 9. Retail Pharmacy
Figure 10. Global Icosapent Ethyl Soft Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Icosapent Ethyl Soft Capsules Market Size (2019-2030) & (US$ Million)
Figure 12. Global Icosapent Ethyl Soft Capsules Sales (2019-2030) & (K Units)
Figure 13. Global Icosapent Ethyl Soft Capsules Average Price (US$/Unit) & (2019-2030)
Figure 14. Icosapent Ethyl Soft Capsules Report Years Considered
Figure 15. Icosapent Ethyl Soft Capsules Sales Share by Manufacturers in 2023
Figure 16. Global Icosapent Ethyl Soft Capsules Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Icosapent Ethyl Soft Capsules Players: Market Share by Revenue in 2023
Figure 18. Icosapent Ethyl Soft Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Icosapent Ethyl Soft Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Icosapent Ethyl Soft Capsules Sales Market Share by Country (2019-2030)
Figure 21. North America Icosapent Ethyl Soft Capsules Revenue Market Share by Country (2019-2030)
Figure 22. United States Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Icosapent Ethyl Soft Capsules Sales Market Share by Country (2019-2030)
Figure 25. Europe Icosapent Ethyl Soft Capsules Revenue Market Share by Country (2019-2030)
Figure 26. Germany Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Icosapent Ethyl Soft Capsules Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Icosapent Ethyl Soft Capsules Revenue Market Share by Region (2019-2030)
Figure 33. China Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Icosapent Ethyl Soft Capsules Sales Market Share by Country (2019-2030)
Figure 41. Latin America Icosapent Ethyl Soft Capsules Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Icosapent Ethyl Soft Capsules Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Icosapent Ethyl Soft Capsules Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Icosapent Ethyl Soft Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Icosapent Ethyl Soft Capsules by Specification (2019-2030)
Figure 52. Global Revenue Market Share of Icosapent Ethyl Soft Capsules by Specification (2019-2030)
Figure 53. Global Icosapent Ethyl Soft Capsules Price (US$/Unit) by Specification (2019-2030)
Figure 54. Global Sales Market Share of Icosapent Ethyl Soft Capsules by Application (2019-2030)
Figure 55. Global Revenue Market Share of Icosapent Ethyl Soft Capsules by Application (2019-2030)
Figure 56. Global Icosapent Ethyl Soft Capsules Price (US$/Unit) by Application (2019-2030)
Figure 57. Icosapent Ethyl Soft Capsules Value Chain
Figure 58. Icosapent Ethyl Soft Capsules Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
